Shares in consumer healthcare group Venture Life (VLG) exceeded 70p in February this year and the group recently announced results emphasising it “delivering 16% topline growth on a like for like basis in the current trading environment… and extraordinary growth prospects in the exciting consumer healthcare market, we look ahead to the new financial year with confidence”.
Venture Life Group (VLG) has announced completion of the sale of its contract development and manufacturing operations and some, non-core, products and “confidence that full year financial performance is on-course to be in line with market expectations”. How does this latest news compare to a share price at 58.5p compared to a 39.5p offer price tip just in November?
Venture Life Group (VLG) has announced an agreement to sell its contract development and manufacturing business and some ‘non-core’ products and associated commercial agreements to portfolio company of investment firm The Riverside Company, BioDue, for €62 million on a cash-free debt-free basis. With Venture Life’s market cap having been £57.6 million at a 45p share price, just how good is this news?
‘Self-care’ products group Venture Life (VLG) has announced a trading update for its year ended 31st December 2024 and that it is “extremely positive for the outlook for growth in both our revenues and profitability in 2025”. So good news from a 34p share price?
Following results and acquisition announcements in the last couple of months, shares in consumer self-care products developer and manufacturer Venture Life Group (VLG) have fallen back from approaching 50p to below 40p. However, the following is why we consider they have the potential to exceed 50p again.
‘Self-care’ products group Venture Life (VLG) commences a trading update with that it “expects to report revenues for the six months ended 30 June 2022 of £18.9 million, a growth of 36% over the same period previous year” and adds “order book remains strong and is ahead of the same period last year”. So what of a current share price response up more than 9% at 35p?
‘Self-care’ products group Venture Life (VLG) has made a trading statement and the shares have currently responded to around 50p, 34% higher, on the back of it. Is this justified?...
Describing itself as “a leader in developing, manufacturing and commercialising products for the self-care market”, a “Trading Update & Board Changes” announcement from Venture Life Group (VLG) includes “the directors see many reasons to be optimistic and are pleased with how the company is positioned… The company is profitable, cash generative, with a healthy cash balance… order book ahead of where it was at the same time last year (on a like for like basis)”. So why then are the shares, at circa 35p, 27% lower on the back of it?...
